Cite
HARVARD Citation
Guy, S. et al. (2021). Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT). Clinical and applied thrombosis/hemostasis. p. . [Online].